A treatment for relapsed multiple myeloma, a blood supply screening device & 2 more FDA approvals

Four drugs or medical devices approved by the FDA since July 5:

Advertisement

1. Xpovio was approved in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma.

2. Katerzia is an amlodipine oral suspension for the treatment of high blood pressure in adults and pediatric patients ages 6 and older. 

3. Alinity s System is a device to screen the nation’s blood and plasma supply to protect against infected blood. 

4. ProVate, a vaginal ring pessary, was approved for the temporary, nonsurgical management of pelvic organ prolapse in women. 

More articles on pharmacy:
Judge blocks HHS rule requiring drug prices in TV ads
Nation’s 1st prescription drug affordability board goes into effect
11 healthcare pharma leaders offer advice on controlling drug spend

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.